Stratosvir
PrivateLast Round
VC Round
Apr 28, 2026
Total Funding Raised
$680,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stratosvir operates in Healthcare & Life Sciences and is based in Ingatestone. Its latest recorded funding round was a VC Round in April 2026.
Stratosvir is a biotechnology company that develops viral immunotherapy solutions to treat solid tumors and their metastases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stratosvir Comparables
Compare Stratosvir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TrustFlight | 84% | |
| ModernHawk | 81% | |
| Aviation InterTec Services | 81% |
For institutional investors. Book with your work email.
Stratosvir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 28, 2026 | ||||
| Grant | Oct 21, 2024 | ||||
| Seed | Jun 6, 2024 | ||||
| Pre Seed | Dec 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stratosvir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Science Ventures | Pre Seed |
| o2h ventures | Seed |
| Cell and Gene Therapy Catapult | VC Round |
| Innovate UK | Grant |
| Proven Connect | Seed |
| Cancer Research Horizons | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Raised a VC Round with Cell and Gene Therapy Catapult.
- Oct 21, 2024
$616K raised from Innovate UK.
For institutional investors. Book with your work email.
Stratosvir Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stratosvir's valuation, stock price, and market status.
Is Stratosvir a public or private company?
Stratosvir is a private company.
What is the current stock price of Stratosvir?
Stratosvir is a private company, so its shares have no public market price. Caplight tracks Stratosvir's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stratosvir worth (valuation)?
Valuation information for Stratosvir is not publicly available.
Can I buy Stratosvir stock?
Stratosvir shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stratosvir's last funding round?
Stratosvir's most recent funding round was VC Round on April 28, 2026.
Who are the main investors in Stratosvir?
Key investors in Stratosvir include Deep Science Ventures, o2h ventures, Cell and Gene Therapy Catapult, Innovate UK, Proven Connect.
Will Stratosvir IPO soon?
No public IPO plans have been announced for Stratosvir.
How can I track Stratosvir secondary market activity?
Caplight tracks bids, offers, and trades in Stratosvir's shares on secondary markets.